G. Valinciute

BET-bromodomain inhibitors modulate epigenetic patterns at the diacylglycerol kinase alpha enhancer associated with radiation-induced fibrosis.

C. Plass, F. Wenz, P. Schmezer, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

MEDU-01. HDACi AND PLK1i ACT SYNERGISTICALLY IN MYC-AMPLIFIED MEDULLOBLASTOMA

S. Pfister, J. Krijgsveld, T. Hielscher, 2019, Neuro-Oncology.

BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma.

David C. Jones, S. Pfister, A. von Deimling, 2022, Neuro-oncology.

Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells

David C. Jones, M. Roussel, M. Kool, 2023, Journal of Neuro-Oncology.

Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma.

F. Westermann, M. Kool, N. Jäger, 2020, Neuro-oncology.

Targeting protein folding in N‐Myc‐driven medulloblastoma

M. Roussel, G. Valinciute, 2023, Molecular Oncology.

Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells

T. Hielscher, T. Milde, I. Oehme, 2023, Journal of Neuro-Oncology.